# A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer

> **NCT00359359** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 26 (actual)

## Conditions studied

- Carcinoma, Small Cell

## Interventions

- **DRUG:** Sagopilone (BAY86-5302, ZK 219477)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00359359
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359359, "A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00359359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*